We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-7.37%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$310M
AUM Growth
-$104M
Cap. Flow
-$74.9M
Cap. Flow %
-24.14%
Top 10 Hldgs %
43.58%
Holding
95
New
25
Increased
9
Reduced
24
Closed
33

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$18.9M
2
AGN
Allergan plc
AGN
+$16.4M
3
PFE icon
Pfizer
PFE
+$11M
4
MCK icon
McKesson
MCK
+$8.96M
5
COR icon
Cencora
COR
+$8.86M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$15.2M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$12.1M
3
MEDP icon
Medpace
MEDP
+$10.2M
4
NVS icon
Novartis
NVS
+$8.3M
5
HUM icon
Humana
HUM
+$7.51M

Sector Composition

Rank Sector Weight
1 Healthcare 82.23%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
76
PUT
Merck
MRK
$322B
-104,800
Closed -$8.38M
NTRA icon
77
Natera
NTRA
$38.3B
-145,500
Closed -$4.01M
NVS icon
78
Novartis
NVS
$297B
-90,870
Closed -$8.3M
OCUL icon
79
Ocular Therapeutix
OCUL
$1.79B
-59,668
Closed -$263K
SENS icon
80
Senseonics Holdings Inc
SENS
$263M
-27,743
Closed -$1.13M
SNN icon
81
Smith & Nephew
SNN
$13.3B
-76,102
Closed -$3.31M
STRO icon
82
Sutro Biopharma
STRO
$401M
-33,906
Closed -$3.86M
SVRA icon
83
Savara
SVRA
$1.12B
-400,000
Closed -$948K
SVRA icon
84
PUT
Savara
SVRA
$1.12B
-414,400
Closed -$982K
UBER icon
85
Uber
UBER
$143B
-90,000
Closed -$4.17M
UBX
86
DELISTED
Unity Biotechnology
UBX
-10,064
Closed -$956K
UNH icon
87
UnitedHealth
UNH
$376B
-29,176
Closed -$7.12M
VRTX icon
88
Vertex Pharmaceuticals
VRTX
$121B
-28,232
Closed -$5.18M
ZBH icon
89
Zimmer Biomet
ZBH
$18.2B
-33,609
Closed -$3.84M
ITCI
90
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-607,800
Closed -$7.89M
FRTX
91
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
-4,221
Closed -$1.13M
CCXI
92
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
-100,000
Closed -$930K
IMMU
93
DELISTED
Immunomedics Inc
IMMU
-70,000
Closed -$971K
DOVA
94
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
-135,133
Closed -$1.91M
LJPC
95
DELISTED
La Jolla Pharmaceutical Company
LJPC
-1,310,367
Closed -$12.1M

Similar funds

Sio Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Sio Capital Management held 95 positions worth $310M, down 25% from $415M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sio Capital Management withdrew a net $74.9M in Q3 2019, closing 33 positions and reducing 24 holdings. Its most notable exit was GSK, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 69% a quarter earlier, followed by Technology.

Against the trend, Sio Capital Management opened a new position in Johnson & Johnson worth $18.6M.

  • Sio Capital Management's largest Q3 2019 buy was Johnson & Johnson: 143,707 shares worth $18.6M.
  • Sio Capital Management added most to GW Pharmaceuticals Plc American Depositary Shares in Q3 2019, an estimated $8.43M increase.
  • Sio Capital Management's biggest Q3 2019 reduction was Medpace, cutting an estimated $10.2M.
  • Sio Capital Management fully exited GSK in Q3 2019, selling an estimated $15.2M.
  • Sio Capital Management's ten largest holdings make up 44% of its $310M portfolio in Q3 2019.
  • Sio Capital Management opened 25 new positions and closed 33 in Q3 2019.
  • Sio Capital Management's portfolio value fell 25% quarter-over-quarter to $310M.

Based on Sio Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.